Skip to main content

Evidence to Improve Care

Home Narrowband Ultraviolet B Phototherapy for Photoresponsive Skin Conditions

Draft Recommendation

  • Health Quality Ontario, under the guidance of the Ontario Health Technology Advisory Committee, recommends publicly funding home narrowband ultraviolet B (UVB) phototherapy as a treatment option for people with photoresponsive skin conditions currently treated with narrowband UVB phototherapy in an outpatient (clinic-based) setting 

Read the draft recommendation report

Thank you for your comments.

The public feedback period for this topic has ended. All comments will be considered before a final recommendation is made and posted here. Use the tabs below to learn more about this topic and download supporting draft documents, including the full assessment report. To be notified once a final recommendation is posted here, sign up for our newsletter.

Some skin conditions can be treated with ultraviolet radiation, which is a type of light that’s not visible. These are defined as photoresponsive skin conditions – the most commonly treated are psoriasis, vitiligo, eczema, and cutaneous T-cell lymphoma (a type of skin cancer). This type of treatment does not cure the condition; often treatment needs to be continued or symptoms may return.

Narrowband ultraviolet B phototherapy is the most common type of therapy for these conditions. It involves exposing the affected person to ultraviolet radiation. Treatment is usually done in an outpatient setting, such as a clinic or doctor’s office. However, people who have difficulty getting to a clinic may benefit from narrowband ultraviolet B phototherapy in their home.

This health technology assessment looked at how safe, effective, and cost-effective home narrowband ultraviolet B phototherapy is for people with some photoresponsive skin conditions. It looked at the budget impact of publicly funding home narrowband ultraviolet B phototherapy. It also looked at the experiences, preferences, and values of people with photoresponsive skin conditions.

Read the full Health Technology Assessment report for more information.

Home Narrowband Ultraviolet B Phototherapy for Photoresponsive Skin Conditions: A Health Technology Assessment (PDF)
October 2019

Use of this site, and the interpretation of the information contained here, is subject to important terms and conditions. Use of this site and information except in accordance with these terms and conditions is expressly prohibited.

About Health Quality Ontario

Health Quality Ontario is the provincial lead on the quality of health care. We help nurses, doctors and other health care professionals working hard on the frontlines be more effective in what they do—by providing objective advice and data, and by supporting them and government in improving health care for the people of Ontario.

We focus on making health care more effective, efficient and affordable through a legislative mandate of:

  • Reporting to the public, organizations, government and health care providers on how the health system is performing,

  • Finding the best evidence of what works, and

  • Translating this evidence into clinical standards; recommendations to health care professionals and funders; and tools that health care providers can easily put into practice to make improvements.

For more information about Health Quality Ontario, visit


Sign up for our newsletter to receive monthly notifications of when draft recommendations are open for feedback

A senior couple looking at their tablet together

Let’s make our health system healthier

Join Our Patient, Family and Public Advisors Program

Patients, families and the public are central to improving health quality.

Man smiling

Sign up for our newsletter

Are you passionate about quality health care for all Ontarians? Stay in-the-know about our newest programs, reports and news.

Health Quality Connect - Health Quality Ontario's newsletter - on an iPad and a cell phone